Dr. Jonathan Usuka

Dr. Jonathan Usuka, CEO of Sapient and expert in bioinformatics, dives into the transformative world of proteomics and metabolomics. He breaks down the complexities of the dark proteome and how understanding these uncharacterized proteins can enhance drug discovery. The conversation highlights the need for longitudinal patient sampling and robust conclusions for biopharma. Usuka also discusses the FDA's evolving perspective on real-world data, crucial for advancing personalized medicine and patient care in biotechnology.